ChemoCentryx: A Biotech Stock Well Worth the Risk - Rickey J. White, Jr. | RJW™
26699
post-template-default,single,single-post,postid-26699,single-format-standard,ajax_fade,page_not_loaded,,qode-theme-ver-16.3,qode-theme-bridge,wpb-js-composer js-comp-ver-5.4.7,vc_responsive
 

ChemoCentryx: A Biotech Stock Well Worth the Risk

09 May ChemoCentryx: A Biotech Stock Well Worth the Risk

Posted at 08:00h in Popular Newsfeed by
0 Likes

In the wake of its first quarter earnings report, ChemoCentryx ran as much as 25% on Friday as the broader market fell. The move could mark an important inflection point…


Source: Entrepreneur.com Lastest News

Tags:
No Comments

Sorry, the comment form is closed at this time.